Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/506
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSmolen, Josef Sen
dc.contributor.authorMiranda, Pedroen
dc.contributor.authorIlivanova, Elenaen
dc.contributor.authorPark, Min-Chanen
dc.contributor.authorPedersen, Ronalden
dc.contributor.authorNash, Peteren
dc.contributor.authorHall, Stephenen
dc.contributor.authorPavelka, Karelen
dc.contributor.authorIrazoque-Palazuelos, Fedraen
dc.contributor.authorDurez, Patricken
dc.date.accessioned2018-06-16T20:34:59Z-
dc.date.available2018-06-16T20:34:59Z-
dc.date.issued2013en
dc.identifier.citation381, (9870), 2013, p. 918-929en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/506-
dc.languageenen
dc.relation.ispartofThe Lanceten
dc.titleMaintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trialen
dc.typeArticleen
dc.identifier.risid558en
dc.description.pages918-929en
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.grantfulltextnone-
item.fulltextNo Fulltext-
Appears in Sites:Queensland Health Publications
Sunshine Coast HHS Publications
Show simple item record

Page view(s)

92
checked on Apr 29, 2025

Google ScholarTM

Check


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.